Source: Annual Congress 2006 - Pulmonary arterial hypertension: from bench back to bedside
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. A. Elliot, R. M. Barraclough, I. J. Armstrong, M. Akil, D. G. Kiely (Sheffield, United Kingdom). Vasodilator testing in pulmonary arterial hypertension associated with systemic sclerosis. Eur Respir J 2006; 28: Suppl. 50, 3164

Member's Comments

No comment yet.

Related content which might interest you: Screening for pulmonary arterial hypertension in systemic sclerosis Source: Eur Respir Rev 2009; 18: 162-169 Year: 2009 Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension Source: Eur Respir J, 52 (4) 1800678; 10.1183/13993003.00678-2018 Year: 2018 Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening Source: Eur Respir Rev 2011; 20: 270-276 Year: 2011 Identifying early pulmonary arterial hypertension in patients with systemic sclerosis Source: Eur Respir J, 51 (4) 1800495; 10.1183/13993003.00495-2018 Year: 2018 Risk assessment in patients with systemic sclerosis and pulmonary arterial hypertension Source: Eur Respir J, 52 (4) 1801745; 10.1183/13993003.01745-2018 Year: 2018 Differences between limited and diffuse systemic sclerosis-related pulmonary arterial hypertension Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011 Pulmonary hypertension and arterial stiffness in patients with systemic scleroderma Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension Source: Eur Respir J 2010; 35: 6-8 Year: 2010 Systemic consequences of pulmonary arterial hypertension Source: International Congress 2019 – State of the art session: Pulmonary vascular diseases Year: 2019 Predictors of pulmonary artery hypertension in patients with systemic sclerosis Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012 Trends in systemic sclerosis and systemic sclerosis-related pulmonary arterial hypertension mortality in the USA Source: ERJ Open Res, 6 (2) 00309-2019; 10.1183/23120541.00309-2019 Year: 2020 Gas transfer relates to pulmonary haemodynamics and survival in pulmonary arterial hypertension associated with systemic sclerosis Source: Eur Respir J 2007; 30: Suppl. 51, 344s Year: 2007 Ventricular mass index correlates with pulmonary haemodynamics in patients with systemic sclerosis and suspected pulmonary arterial hypertension Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 Pulmonary arterial hypertension in scleroderma – manifestation of systemic endothelial dysfunction Source: Eur Respir J 2006; 28: Suppl. 50, 548s Year: 2006 Pulmonary arterial hypertension in systemic sclerosis: a distinctive endotheliopathy? Source: Eur Respir J 2010; 35: 223-224 Year: 2010 Lung function and pulmonary hypertension in systemic sclerosis Source: Eur Respir J 2006; 28: Suppl. 50, 548s Year: 2006 A screening protocol for pulmonary hypertension in systemic sclerosis identifies patients with pulmonary hypertension on exercise Source: Eur Respir J 2004; 24: Suppl. 48, 277s Year: 2004 Acute vasodilator response in different forms of pre-capillary pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Time for precision medicine in systemic sclerosis-associated pulmonary arterial hypertension Source: Eur Respir J, 57 (6) 2100205; 10.1183/13993003.00205-2021 Year: 2021 Iron deficiency in patients with systemic sclerosis-associated pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012